“Double-strength 300 mg extract delivering ~240 mg silymarin”
The label discloses a double-strength (2:1) extract standardized to 80% silymarin, computing to ~240 mg silymarin per capsule.
A strong-value big bottle for anyone who actively wants the traditional liver-herb stack. NOW pairs a real double-strength silymarin dose with artichoke and dandelion — two classic liver-support herbs — in a 200-count bottle from a large, UL-audited GMP manufacturer. The trade-off is scientific tidiness: with three herbs in the capsule you can't cleanly attribute effects to milk thistle alone.
Check on AmazonAffiliate link — Super Achiever Club earns a small commission at no extra cost to you.
Read the complete Milk Thistle (Silymarin) guide →A plain (non-phytosome) 2:1 double-strength silymarin concentrate combined with artichoke and dandelion. Absorption is the standard ceiling, and the blend format means milk thistle isn't the only active — decent form for the money, nothing enhanced.
~240 mg silymarin per capsule from an 80% double-strength concentrate — a real dose in the same range as the value picks, with two caps clearing the trial window.
UL-audited GMP manufacturing and non-GMO status from a large, well-regarded brand. Above brand-only attestations, but there's no independent NSF or USP product seal.
A 200-count bottle for ~$22 is excellent per-capsule value, and the bundled herbs add coverage. Slightly behind the outright cost-per-mg leader, but a lot of bottle for the money.
Vegetarian/vegan capsules and generally well tolerated, but the three-herb blend is the drawback — you can't attribute effects, or a reaction, to milk thistle cleanly.
“Double-strength 300 mg extract delivering ~240 mg silymarin”
The label discloses a double-strength (2:1) extract standardized to 80% silymarin, computing to ~240 mg silymarin per capsule.
“Includes artichoke and dandelion for liver support”
The label lists artichoke and dandelion as additional ingredients — two herbs traditionally used for liver and digestive support.
“UL-audited GMP manufacturing”
NOW Foods manufactures in a UL-audited GMP facility, a documented quality process above brand-only attestation.
“Supports liver detoxification and function”
The blend is traditionally used for liver support, but controlled evidence for silymarin is mixed (Rambaldi 2007), and the artichoke/dandelion additions are not backed by strong outcome trials here.
This isn't trying to be a clean milk thistle isolate — it's a liver-herb blend. Artichoke and dandelion ride along with a real silymarin dose, which is a plus if you want broad 'liver support' and a minus if you want attribution.
200 capsules at ~$22 is roughly $0.11 each — outstanding per-capsule value. It trails Nutricost only on pure cost-per-mg-of-silymarin because part of what you pay for is the extra herbs.
NOW's UL-audited GMP process and scale put its QC above brand-only attestation, even without an independent product seal — a reassuring middle ground on the 20%-weighted testing axis.
With three actives, you can't isolate milk thistle's contribution — and the underlying silymarin evidence is already mixed. Fine as a shelf staple; not the pick for a controlled milk thistle trial of your own.
A strong-value big bottle if you actively want the traditional liver-herb stack — artichoke and dandelion ride along with a real silymarin dose. The trade-off is scientific tidiness: with three herbs in the capsule you lose clean attribution, which is why it sits behind the single-ingredient value pick. Great for a 'liver support' shelf staple, less ideal if you want to isolate what milk thistle is doing.
Check NOW Foods on AmazonThe same silymarin dose without the extra herbs, at the best cost-per-mg here.
See it on the list →A cleaner single-ingredient vegan option — cheaper per cap but a lower dose.
See it on the list →A guaranteed-potency, single-herb one-a-day if attribution matters to you.
See it on the list →No significant mortality benefit of milk thistle was found in liver disease versus placebo.
Narrative review reports supportive liver effects for silymarin at a lower evidence tier than RCTs.